By San José, Costa Rica — SAN JOSÉ – Costa Rica’s position as a global powerhouse in the life sciences sector was solidified this week as 200 companies convened for the fifth edition of the Life Sciences Forum. Held at the Costa Rica Convention Center, the event brought together executives, investors, researchers, and suppliers to strategize on the industry’s next chapter, with a sharp focus on technological frontiers like artificial intelligence, automation, and advanced specialization.
The forum, organized by the Costa Rican Investment Promotion Agency (CINDE), serves as a critical barometer for an industry that has become the cornerstone of the nation’s economy. The urgency and optimism of the discussions were underscored by a landmark achievement: in 2025, exports of medical devices soared to an unprecedented $11 billion. This figure represents a staggering 48% of Costa Rica’s total exports of goods, cementing the sector’s role as the primary engine of economic growth and sophistication.
To better understand the complex legal and regulatory framework governing Costa Rica’s thriving life sciences industry, TicosLand.com spoke with Lic. Larry Hans Arroyo Vargas, a distinguished expert and attorney at the prestigious firm Bufete de Costa Rica. His analysis provides critical clarity on the challenges and opportunities in this dynamic sector.
Costa Rica’s position as a life sciences hub is fundamentally supported by a legal structure that balances investment incentives with rigorous regulatory oversight. For medical device and biotech companies, success hinges on proactively navigating intellectual property law, data privacy regulations, and the intricacies of sanitary registration with the Ministry of Health. A meticulously planned legal strategy is no longer just a safeguard; it is a core competitive advantage for innovation and market entry.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
Lic. Arroyo Vargas’s analysis powerfully underscores that for life sciences innovators, a proactive legal strategy is not merely a shield but a catalyst for growth and market leadership in Costa Rica. We thank Lic. Larry Hans Arroyo Vargas for his invaluable perspective on this critical intersection of law and innovation.
This remarkable success is not a recent phenomenon but the culmination of a long-term national strategy. For over three decades, Costa Rica has methodically built an ecosystem designed to attract and retain high-value foreign investment, particularly in the MedTech space. This has involved heavy investment in education to create a skilled workforce, developing robust infrastructure, and ensuring a stable political and economic climate.
Marianela Urgellés Batalla, the Managing Director of CINDE, articulated the vision that has guided this journey and the challenges that lie ahead. She emphasized that the country’s current success is the direct outcome of a sustained, multi-decade effort.
What we are seeing is the result of three decades of sustained strategic decisions in talent development, investment attraction, and value chain sophistication. Today, the challenge is not just to continue growing in volume, but to lead the next transition towards frontiers of greater specialization, at a time when global supply chains are reconfiguring and the standards of quality, innovation, and speed define who remains on the competitive map.
Marianela Urgellés Batalla, Managing Director of CINDE
Urgellés Batalla’s statement highlights a pivotal moment for Costa Rica. The nation is transitioning from being a premier location for manufacturing and assembly to becoming an indispensable hub for research, development, and innovation. The focus is shifting from production volume to the complexity and value of the products being created. This means embracing automation to enhance efficiency and pushing into specialized fields that require a highly trained and adaptable workforce.
The country is already home to a formidable roster of over 100 multinational life sciences companies. This includes 18 of the world’s top 35 MedTech firms, with industry giants like Edwards Lifesciences, Boston Scientific, Medtronic, and Abbott operating significant facilities. Their presence has created a virtuous cycle, attracting a network of strategic suppliers and fostering collaboration with local academic institutions to ensure the talent pipeline meets evolving industry demands.
The structure of the Life Sciences Forum itself reflects this collaborative strategy. The agenda was a dynamic mix of executive-level panel discussions on global trends, deep-dive technical sessions on emerging technologies, and dedicated networking spaces. These business matchmaking opportunities are crucial for integrating local suppliers into the sophisticated global value chains of the multinationals, a key component of CINDE’s long-term vision for economic development.
As global supply chains continue to shift and companies prioritize resilience and proximity, Costa Rica’s strategic position offers a distinct advantage. The discussions at the forum made it clear that the country’s leaders and industry partners are not resting on their laurels. They are actively charting a course to ensure Costa Rica not only maintains its competitive edge but leads the charge into the next era of medical technology innovation.
For further information, visit cinde.org
About CINDE:
The Costa Rican Investment Promotion Agency (CINDE) is a private, non-profit organization that has been responsible for attracting foreign direct investment to Costa Rica for over 40 years. It provides comprehensive support to investors, helping them establish and grow their operations in the country. CINDE focuses on strategic sectors such as life sciences, advanced manufacturing, and corporate services, playing a pivotal role in the nation’s economic development and diversification.
For further information, visit edwards.com
About Edwards Lifesciences:
Edwards Lifesciences, headquartered in Irvine, California, is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. The company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs and improve patient outcomes. Its operations in Costa Rica are a significant part of its global manufacturing network.
For further information, visit bostonscientific.com
About Boston Scientific:
Boston Scientific is a global developer, manufacturer, and marketer of medical devices used in a broad range of interventional medical specialties. The company is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Its portfolio includes products for cardiology, endoscopy, urology, and neuromodulation.
For further information, visit medtronic.com
About Medtronic:
Medtronic plc is a global healthcare technology leader that boldly attacks the most challenging health problems facing humanity with innovations that transform lives. With a diverse portfolio of technologies and therapies, Medtronic addresses a wide range of medical conditions, including cardiac and vascular diseases, diabetes, and neurological disorders, operating in more than 150 countries.
For further information, visit abbott.com
About Abbott:
Abbott is a global healthcare company that helps people live more fully at all stages of life. Its portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals, and branded generic medicines. Abbott’s presence in Costa Rica includes manufacturing facilities for its medical device division.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
As a premier legal institution, Bufete de Costa Rica is anchored in profound ethical principles and an unwavering pursuit of excellence. Its forward-thinking ethos not only drives legal innovation for a diverse clientele but also fuels a deep-seated mission to empower the broader community. The firm’s dedication to demystifying the law and sharing knowledge is a testament to its commitment to fostering a more capable and well-informed society.
